Ranjan Sinha, Founder, CEO

Size: px

Start display at page:

Download "Ranjan Sinha, Founder, CEO"

Tyrone Ross
5 years ago
Views:

1 Ranjan Sinha, Founder, CEO

2 PROBLEM: DIABESITY Diabesity = Obesity or Pre-diabetes or T2D or High TGL 1 Ravages 50 million Americans 2 The genetic risk and rates of disease varies significantly across ethnicity.

3 EVIDENCE AND RECOGNITION...there is not a One-Size-Fits-All" eating 40/200 pattern for individuals with diabetes.. Low Carb Diet? Glycemic Index? ~ American Diabetes Association, /200 Low Fat Diet?

4 CORE TECHNOLOGY PERSONALIZED WELLNESS PLATFORM USDA FOOD CLOUD Search Across 500,000 Recipes PERSONALIZED NUTRITION SOLUTIONS GENOTYPE BIOME Curated Research 3TandAi Cloud Heuristics METABOLIC MARKERS LIFESTYLE PUBLIC GENOME & BIOME DATA CLOUD BESPOKE FOOD SOLUTIONS * optional

5 PRODUCTS DTC (Gateway Product) Nutrition, Exercise, Skin, Vitamin. Recipe finder, Meal Planner. B2B2C Wellness Program Sold only through MDs, Dieticians and Wellness Professionals B2B2C Personalized Corporate Wellness Program 16 week Program Direct Sales Force Want to Eat Better + HEALTH RISK Engage health insurance and corporate food partners

6 MARKET SEGMENTS AND POTENTIAL DIABESITY Mexicans 10m $24B African American Indian/South Asians 700K $1.7B Chinese 650K $1.6B Filipino 530K $1.3B 6m $15B White 16m $38B RISK

7 COMPETITION Habit Day Two DNA Fit Omada Health GENETIC DATA Y Y X Y X X X GUT BIOME DATA Y X Y X X X X ETHNIC SPECIFIC MARKERs Y X X X X X X PERSONALIZED NUTRITION Y Y Y Y X X X OFFERS DIABESITY Y X X X Y Y Y COMPREHENSIVE Genome Biome Metabolism GENERAL WELLNESS X Y X Y X X X CONDUCTING HUMAN TRIALS Y X Y X Y Y X WORKS WITH BESPOKE FOOD MFG SYSTEMS OPTIMIZED For ethnic effectiveness FOCUSED On Diabesity Virta Y X X X X X X Vida

8 WHAT HAS BEEN ACHIEVED SEED FUNDING Convertible note PRODUCT Live. Generating Revenue. CDC DPP PRODUCT TEAM On board Architect, UXUI, Analysts, SW engineers HUMAN TRIAL IRB Approved. Starts April 15 th. Research manager hired. Recruitment plan ready. PERSONALIZED FOOD PROJECT Phase Two USA Government funded. 3D FOOD PRINTING COMPANY Partnership signed. Pilot product Two corporate Starts July planned for trial partners. Q4 2 5

9 THREE PHASE PLAN PHASE 3 Blue Sky Opportunities New health areas. International Marketplace (2023- PHASE Market Growth Scale Wellness and Bespoke food. 275,000 Clients Incorporate Medicare Participants PHASE Market Entry Finish Human trials (Pilot:April Sept) Establish Beachhead Launch bespoke foods with partners 5,000 Clients

10 OUR TEAM + ADVISORS RANJAN SINHA Founder CEO Dr. JAEYUN SUNG Bioinformatics Mayo Clinic Dr. Ronesh Sinha MD Dr. Sean Bourke MD Dr. Cesar Molina MD Dr. Ken Albala Food Historian Author Prajakta Ranade Diabetes Nutritionist Stanford Medical Dr. Ahmed El-Sohemy Prof. Nutrition & Genes Dr. Larry Kaskel MD Dr. Fahim Abbasi MD Dr. Mima Geere MS NUTRITION Richard Blossom CEO Perfect Earth Dr. Abdur Rub, Phd PHILIP PAN Product Designer UC Berkeley ROSHNI RAY Science and Research Officer UBiome MIT; UC Berkeley Dr. Akil Palanisamy MD + 4 software engineers + Analyst + Marketing Dr. Rajesh Dash MD, Phd

11 INVESTOR VALUE PROPOSITION B global market. 2. Well timed, superior, differentiated solution. 3. Proven business, technology team supported by MDs 4. Low Risk. 5. Large data set invaluable to the food industry. 6. Many blue sky opportunities Finally, we have a precise, trackable dietary solution that can be used by physicians and nutritionists to reduce the most critical cardiovascular and metabolic risks. Dr. Rajesh Dash, MD, PhD Stanford Medical " 3TandAi blends individualized nutrition science with knowledge of the culinary arts to provide an easy to adopt personalized food platform. They are a PERFECT resource to prevent and reverse chronic health conditions. Dr. Ron Sinha, Dir. Corporate Wellness, Sutter Health.

12 FINANCIAL PROJECTIONS UNIT SALES Total Kit Sales 822 5,685 22,943 65, ,822 Kits Sold thru Corporate Wellness Partnership 55 1,180 7,943 29, ,822 * Total Revenue $253,036 $2,055,418 $9,037,959 $27,668,291 $78,745,880 Total COGS $171,700 $1,299,680 $4,354,276 $12,589,897 $35,545,407 Gross Profit $81,336 $755,738 $4,683,682 $15,078,394 $43,200,473 GROSS MARGIN 32% 37% 52% 54% 55% Total Expense 1,145,667 4,617,325 9,401,356 16,559,059 29,399,100 Operating Profit $1,064,331 $3,861,588 $4,717,674 $1,480,664 $13,801,373 Year End Headcount Market Share 0.0% 0.2% 0.6% 1.3% 3.0% A) Total Kits Sold = 275,000 B) Series A Cash takes us thru Dec C) Peak Operating Cash required - $ 13 M Series Q = $2.0M Series B = $15 mil (Q4 2019) * Weightwatchers had 1.1 million active subscribers end of 2016 paying $53 per month Financials 3 Month Churn

13 WHY NOW Functional Medicine Fastest growing segment Business wants to invest in preventive health Consumers want empowerment

Corporate Presentation Fourth Quarter 2017

Corporate Presentation Fourth Quarter 2017 November 2017 1 Safe harbor statement This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as